Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550210 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02550210 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT02550210, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
In this study, the investigators will enroll women with palpable cancers to assess the accuracy of the Breast Cancer Locator (BCL) and the concomitant procedure as a vehicle to optimize and validate the approach in such surgical cases. This approach of adopting palpable cancer patients before initiating an evaluative trial of the BCL in non-palpable breast cancer cases ensures that the BCL does not substantially alter or modify the standard-of-care procedure.
Interventions
- DEVICE Breast Cancer Locator (BCL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02550210
The ClinicalTrials.gov registry entry for NCT02550210 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Locator (BCL) is the first listed.
NCT02550210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02550210 about?
NCT02550210 is a clinical study titled "A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers". In this study, the investigators will enroll women with palpable cancers to assess the accuracy of the Breast Cancer Locator (BCL) and the concomitant procedure as a vehicle to optimize and validate the approach in such surgical cases. This approach of adopting palpable cancer patients before initia...
What is the current status of trial NCT02550210?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-08. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02550210?
The interventions under investigation include: Breast Cancer Locator (BCL) (DEVICE).
Who is sponsoring clinical trial NCT02550210?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.